 |
3rd Annual Biorepositories Conference
Your actions today to preserve precious biological samples will significantly impact your future drug development and revenue, and drive forward biospecimen science.
- Are you looking to build your own biorepository from the ground up?
- Are you afraid your biorepository is not adhering to current regulatory and industry guidelines?
- Do you want the best automation equipment for optimal sample storage practices?
- Do you want to know how to turn your biobank into a strategic asset?
- Are you ready to realize the future scientific opportunities proffered by optimal biospecimen storage?
|
 |
What Makes 2010 Different From The Past?
- Bring home new insights from 8 all new case studies from GlaxoSmithKline, Pfizer, Takeda, Dow Agrosciences, and more
- Hear new white paper updates from the IPWG (Industry Pharmacogenomics Working Group) on standards and best practices across the biopharma industry
- Direct your focus towards the future of biospecimen biobanking with 3 case studies from both pharma and academia on utilizing biobanking best practices to drive forward biospecimen science, biomarker discovery, and drug development
|